From: Differential expression of selected histone modifier genes in human solid cancers
Gene | Sample | Frequency | Sequence Alteration | Codon |
---|---|---|---|---|
SUV39H1 | 4 Ov. Tum. | 2% | IVS2-69G>C | |
1 Ov. Tum. | 0.5% | 525C>T | F260F | |
SUV39H2 | 1 Br. Tum. | 0.5% | 55insT(5'UTR) | |
4CR, 1 Ov, 1 Br.Tumour, 1 Ov. Cell Line | (4%) | 442A>C | R74Q | |
14 Ca.CL., 7 CR, 12Br, 12 Ov. Tum. | 20% | 1008C>T | Y336Y | |
3 Br., 1 Ov. Tum. | 2%. | 1083C>G | L361L | |
HDAC1 | 1 Br. Tum | 0.5% | 1212G>A | A383A |
HDAC2 | 10 Ca. CL, 14 Br, 7 Ov, 3 CR Tum. | 18% | 143InsCAG (5'UTR) | |
19 Ca. CL., 4 CR, 29 Br, 7 Ov. Tum. | 32% | IVS4+30T>A | ||
2 Ov., 1 Br. Tum. | 1.6%. | IVS4-9C>A | ||
15 Ca. CL., 5 CR, 4 Br, 1 Ov. Tum. | 14% | IVS11-13A>G | ||
1 Ov. Ca. CL., Lymphocyte | 1.1% | IVS13-26A>T |